Lesley A. Stevens
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Lesley A. Stevens has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Andrew S. Levey
Tufts–New England Medical Center, Boston, Massachusetts
10 shared publicationsJosef Coresh
Johns Hopkins Medical Institutions, Baltimore, Maryland
5 shared publicationsTom Greene
Department of Quantitative Health Sciences, Cleveland Clinic Foundation, Cleveland, OH
5 shared publications- Christopher H. Schmid
Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island
3 shared publications Frederick Van Lente
Department of Clinical Pathology, Cleveland Clinic Foundation, Cleveland, OH
3 shared publicationsYaping (Lucy) Zhang
Division of Nephrology, Tufts-New England Medical Center, Boston, MA
3 shared publications
Latest Publications
- 1 April 2008
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 51 (4) , S77-S82
Standardization of Serum Creatinine and Estimated GFR in the Kidney Early Evaluation Program (KEEP)
- 1 April 2008
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 51 (4) , S77-S82
Standardization of Serum Creatinine and Estimated GFR in the Kidney Early Evaluation Program (KEEP)
- Open Access
- 1 March 2008
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 51 (3) , 353-357
CKD in the Elderly—Old Questions and New Challenges: World Kidney Day 2008
- 1 March 2008
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 51 (3) , 353-357
Open AccessCKD in the Elderly—Old Questions and New Challenges: World Kidney Day 2008
- Top Cited Papers
- 1 March 2008
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 51 (3) , 395-406
Estimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD
- 1 March 2008
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 51 (3) , 395-406
Top Cited PapersEstimating GFR Using Serum Cystatin C Alone and in Combination With Serum Creatinine: A Pooled Analysis of 3,418 Individuals With CKD
- Top Cited Papers
- 1 October 2007
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 18 (10) , 2749-2757
Evaluation of the Modification of Diet in Renal Disease Study Equation in a Large Diverse Population
Glomerular filtration rate (GFR) estimates facilitate detection of chronic kidney disease. Performance of the Modification of Diet in Renal Disease (MDRD) Study equation varies substantially among populations. To describe the performance of the equation in a large, diverse population, estimated GFR (eGFR) was compared to measured GFR (mGFR) in a cross-sectional analysis of 5504 participants in 10 studies that included measurements of standardized serum creatinine and urinary clearance of iothalamate. At eGFR 2, the MDRD Study equation had lower bias and higher precision than at eGFR ≥60 ml/min per 1.73 m2. The accuracy of the equation, measured by the percent of estimates that fell within 30% of mGFR, was similar for eGFR values above or below 60 ml/min per 1.73 m2 (82% and 84%, respectively). Differences in performance among subgroups defined by age, sex, race, diabetes, transplant status, and body mass index were small when eGFR was 2. The MDRD Study equation therefore provides unbiased and reasonably accurate estimates across a wide range of subgroups when eGFR is 2. In individual patients, interpretation of GFR estimates near 60 ml/min per 1.73 m2 should be interpreted with caution to avoid misclassification of chronic kidney disease in the context of the clinical setting.
- 1 October 2007
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 18 (10) , 2749-2757
Top Cited PapersEvaluation of the Modification of Diet in Renal Disease Study Equation in a Large Diverse Population
Glomerular filtration rate (GFR) estimates facilitate detection of chronic kidney disease. Performance of the Modification of Diet in Renal Disease (MDRD) Study equation varies substantially among populations. To describe the performance of the equation in a large, diverse population, estimated GFR (eGFR) was compared to measured GFR (mGFR) in a cross-sectional analysis of 5504 participants in 10 studies that included measurements of standardized serum creatinine and urinary clearance of iothalamate. At eGFR 2, the MDRD Study equation had lower bias and higher precision than at eGFR ≥60 ml/min per 1.73 m2. The accuracy of the equation, measured by the percent of estimates that fell within 30% of mGFR, was similar for eGFR values above or below 60 ml/min per 1.73 m2 (82% and 84%, respectively). Differences in performance among subgroups defined by age, sex, race, diabetes, transplant status, and body mass index were small when eGFR was 2. The MDRD Study equation therefore provides unbiased and reasonably accurate estimates across a wide range of subgroups when eGFR is 2. In individual patients, interpretation of GFR estimates near 60 ml/min per 1.73 m2 should be interpreted with caution to avoid misclassification of chronic kidney disease in the context of the clinical setting.
- 1 August 2007
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 50 (2) , 169-180
Testing for Chronic Kidney Disease: A Position Statement From the National Kidney Foundation
- 1 August 2007
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 50 (2) , 169-180
Testing for Chronic Kidney Disease: A Position Statement From the National Kidney Foundation
- 1 July 2007
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 50 (1) , 21-35
Impact of Creatinine Calibration on Performance of GFR Estimating Equations in a Pooled Individual Patient Database
- 1 July 2007
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 50 (1) , 21-35
Impact of Creatinine Calibration on Performance of GFR Estimating Equations in a Pooled Individual Patient Database
- 1 July 2006
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 1 (4) , 874-884
Surrogate End Points for Clinical Trials of Kidney Disease Progression
- 1 July 2006
- Published by Wolters Kluwer Health in Clinical Journal of the American Society of Nephrology
- Vol. 1 (4) , 874-884
Surrogate End Points for Clinical Trials of Kidney Disease Progression
- Top Cited Papers
- 8 June 2006
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (23) , 2473-2483
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
In the coming years, estimates of the glomerular filtration rate (GFR) may replace the measurement of serum creatinine as the primary tool for the assessment of kidney function. Indeed, many clinical laboratories already report estimated GFR values whenever serum creatinine is measured. This review considers current methods of measuring GFR and GFR-estimating equations and their strengths and weaknesses as applied to chronic kidney disease.
- 8 June 2006
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 354 (23) , 2473-2483
Top Cited PapersAssessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
In the coming years, estimates of the glomerular filtration rate (GFR) may replace the measurement of serum creatinine as the primary tool for the assessment of kidney function. Indeed, many clinical laboratories already report estimated GFR values whenever serum creatinine is measured. This review considers current methods of measuring GFR and GFR-estimating equations and their strengths and weaknesses as applied to chronic kidney disease.
- 1 August 2005
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (8) , 2439-2448
Low Rates of Testing and Diagnostic Codes Usage in a Commercial Clinical Laboratory
Improving outcomes for chronic kidney disease (CKD) requires early identification and recognition by physicians. There are few data on rates of testing or use of diagnostic codes for CKD. A cross-sectional analysis was performed of patients who were older than 40 yr and had one or more laboratory tests between April 1, 2002, and March 31, 2003, at a Laboratory Corporation of America regional laboratory. Objectives were to determine the frequency of testing for serum creatinine; prevalence of CKD, defined as estimated GFR 60 yr were more likely to be tested for serum creatinine with odds ratio (OR; 95% confidence interval) of 2.09 (2.05 to 2.14), 1.22 (1.19 to 1.25), and 1.24 (1.22 to 1.27) respectively. Among patients tested, 30% had CKD. Sensitivity and specificity of kidney disease diagnostic codes compared with CKD defined by estimated GFR 60 years, and CVD, rates of testing and sensitivity of diagnostic codes were 53 and 14%, respectively. Low rates of testing for serum creatinine and insensitivity of diagnostic codes for CKD, even in high-risk patients, suggests inadequate physician awareness of CKD and limited utility of administrative databases for identification of patients with CKD.
- 1 August 2005
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (8) , 2439-2448
Low Rates of Testing and Diagnostic Codes Usage in a Commercial Clinical Laboratory
Improving outcomes for chronic kidney disease (CKD) requires early identification and recognition by physicians. There are few data on rates of testing or use of diagnostic codes for CKD. A cross-sectional analysis was performed of patients who were older than 40 yr and had one or more laboratory tests between April 1, 2002, and March 31, 2003, at a Laboratory Corporation of America regional laboratory. Objectives were to determine the frequency of testing for serum creatinine; prevalence of CKD, defined as estimated GFR 60 yr were more likely to be tested for serum creatinine with odds ratio (OR; 95% confidence interval) of 2.09 (2.05 to 2.14), 1.22 (1.19 to 1.25), and 1.24 (1.22 to 1.27) respectively. Among patients tested, 30% had CKD. Sensitivity and specificity of kidney disease diagnostic codes compared with CKD defined by estimated GFR 60 years, and CVD, rates of testing and sensitivity of diagnostic codes were 53 and 14%, respectively. Low rates of testing for serum creatinine and insensitivity of diagnostic codes for CKD, even in high-risk patients, suggests inadequate physician awareness of CKD and limited utility of administrative databases for identification of patients with CKD.
- 1 May 2005
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (3) , 457-473
Measurement of Kidney Function
- 1 May 2005
- Published by Elsevier in Medical Clinics of North America
- Vol. 89 (3) , 457-473
Measurement of Kidney Function